- About EAS
Prof. Maciej Banach was an Undersecretary of State at the Ministry of Science and Higher Education of the Republic of Poland (2010-2012). He is a President of Polish Mother's Memorial Hospital - Research Institute (February 2014-), full Professor of Cardiology at the Medical University of Lodz, Head of Foreign Affairs Office (2012-2014), Head of Department of Hypertension (2008-) at the Medical University of Lodz and Professor in the Department of Nephrology, Hypertension and Family Medicine, Chair of Nephrology and Hypertension, at the WAM University Hospital in Lodz, Poland (2009-). He is a Founder and Head of the Polish Lipid Association (PoLA) (2011-) - the official partner of National Lipid Association (NLA, US) and Lodz Chapter of Polish Society of Hypertension (2009-). He is the founder of the Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group (2012) – a group of worldwide experts aimed to investigate the most important issues in the field of lipid disorders and hypertension. He is a Visiting Professor of University of Alabama at Birmingham (UAB) and University of Medicine and Pharmacy Victor Babes in Timisoara, Romania (2014-).
Prof. Banach has published more than 500 original articles, reviews, editorials and book chapters in the field of hypertension, dyslipidemia, cardiology, cardiac surgery, and risk stratification (242 acc. to PubMed, 302 acc. to Web of Knowledge, 304 acc. to SCOPUS, and 514 acc. to Google Scholar). His combined IF (for only full-text manuscripts) is over 1200 pts., number of citations: 2813 (acc. Web of Science Core Collection), 3541 (acc. SCOPUS), and 5001 (acc. Google Scholar), Hirsch’s Index = 26 (WoS), 30 (SCOPUS), and 37 (i10-index: 136) (Google Scholar).
He is Editor-in-Chief of the Archives of Medical Science (IF 2014 = 2.030) and Cardiovascular Continuum, Regional Associate Editor of European Heart Journal – Quality of Care and Clinical Outcomes, Deputy Editor of Thyroid Research and Clinical and Experimental Medical Letters (2007-2012), Associate/Section Editor of Recent Patents on Cardiovascular Drugs Discovery and The Open Atherosclerosis & Thrombosis Journal and member of Editorial Advisory Board of over 30 international medical journals. He is Reviewer of over 80 international journals, including Lancet Diabetes & Endocrinology, Circulation, British Medical Journal and Journal of American College of Cardiology; editor or author of 31 books (102 chapters).
He is a fellow of the Council for High Blood Pressure Research of the American Heart Association (FAHA), National Lipid Association (FNLA), American Society of Angiology (FASA), European Society of Cardiology (FESC), Royal Society for Public Health (FRSPH) and Society of Geriatric Cardiology (FSGC; 2008-2010). He is a member of the working-core of Alliance for Biomedical Research/European Council for Health Research (2011-2013), steering committee of European Innovation Partnership in Active and Healthy Ageing (2010-2012) at the European Commission, member of the European Commission's Scientific Panel for Health (SPH) (2014-), and steering committee of Centre for Good Aging / Healthy Ageing Research Center (HARC) at the Medical University of Lodz, member of Committee for Public Health of the Polish Academy of Sciences, member of the Scientific Board of Institute of Sport in Warsaw, Poland.
He is a laureate of several prizes and award, including: The Personality of the Year 2013 in Poland for the development of science in the field of healthcare – founded by the Heath Manager journal (Termedia Publishing House), Super-Talent in Medicine 2012 Award – the winner of the competition for young scientists in medicine (up to 40) founded by Puls Medycyny journal; scientific awards of Ministry of Health of Republic of Poland for the cycle of publications (2009, 2011), 18 individual and group scientific awards of President of Medical University of Lodz (2009-2015); START Award (2008) and Conferences Awards (2005, 2007) of Foundation for Polish Science, Polityka journal Awards for Young Scientists (2006), and Travel Grants of European Society of Hypertension (2007) and Heart Failure Association of ESC (2005, 2007).
His main area of scientific interests concerns hypertension aspects (risk stratification, prehypertension, new biomarkers, optimal level of BP - J-curve phenomenon, pharmacotherapy/combined therapy, prevention, complications), lipid disorders (risk stratification, new biomarkers, diagnosis, rare diseases), dyslipidemia therapy (statins, new drugs combined treatment) and new drugs in CVD therapy.